MedX Health Corp (MDX) - Net Assets
Based on the latest financial reports, MedX Health Corp (MDX) has net assets worth CA$-10.02 Million CAD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$1.26 Million) and total liabilities (CA$11.28 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$-10.02 Million |
| % of Total Assets | -798.27% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
MedX Health Corp - Net Assets Trend (2013–2024)
This chart illustrates how MedX Health Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MedX Health Corp (2013–2024)
The table below shows the annual net assets of MedX Health Corp from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CA$-8.52 Million | -19.35% |
| 2023-12-31 | CA$-7.14 Million | -0.86% |
| 2022-12-31 | CA$-7.08 Million | -95.05% |
| 2021-12-31 | CA$-3.63 Million | -75.37% |
| 2020-12-31 | CA$-2.07 Million | +27.79% |
| 2019-12-31 | CA$-2.87 Million | -85.64% |
| 2018-12-31 | CA$-1.54 Million | -2.80% |
| 2017-12-31 | CA$-1.50 Million | +17.70% |
| 2016-12-31 | CA$-1.83 Million | +23.68% |
| 2015-12-31 | CA$-2.39 Million | -5.79% |
| 2014-12-31 | CA$-2.26 Million | +33.44% |
| 2013-12-31 | CA$-3.40 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to MedX Health Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3299671400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CA$45.98 Million | % |
| Total Equity | CA$-8.52 Million | 100.00% |
MedX Health Corp Competitors by Market Cap
The table below lists competitors of MedX Health Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Phio Pharmaceuticals Corp
NASDAQ:PHIO
|
$14.24 Million |
|
Greenridge Exploration Inc.
F:HW3
|
$14.24 Million |
|
Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC
|
$14.25 Million |
|
Spirent Communications plc
LSE:SPT
|
$14.25 Million |
|
JOY SPREADER GROUP INC.
F:5YN
|
$14.23 Million |
|
SENSEONICS HLGS.INC.-001
F:6L6
|
$14.23 Million |
|
Vistry Group PLC
LSE:VTY
|
$14.23 Million |
|
Solstice Gold Corp
V:SGC
|
$14.22 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MedX Health Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -7,141,849 to -8,524,100, a change of -1,382,251.
- Net loss of 3,652,971 reduced equity.
- New share issuances of 425,983 increased equity.
- Other factors increased equity by 1,844,737.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$-3.65 Million | -42.85% |
| Share Issuances | CA$425.98K | +5.0% |
| Other Changes | CA$1.84 Million | +21.64% |
| Total Change | CA$- | % |
Book Value vs Market Value Analysis
This analysis compares MedX Health Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | CA$-0.01 | CA$0.06 | x |
| 2018-12-31 | CA$-0.01 | CA$0.06 | x |
| 2019-12-31 | CA$-0.02 | CA$0.06 | x |
| 2020-12-31 | CA$-0.01 | CA$0.06 | x |
| 2021-12-31 | CA$-0.02 | CA$0.06 | x |
| 2022-12-31 | CA$-0.04 | CA$0.06 | x |
| 2023-12-31 | CA$-0.03 | CA$0.06 | x |
| 2024-12-31 | CA$-0.03 | CA$0.06 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MedX Health Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -745.96%
- • Asset Turnover: 0.55x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 0.00% | -326.47% | 0.97x | 0.00x | CA$-1.55 Million |
| 2014 | 0.00% | -23.31% | 1.84x | 0.00x | CA$21.50K |
| 2015 | 0.00% | -42.62% | 1.79x | 0.00x | CA$-260.09K |
| 2016 | 0.00% | -163.43% | 1.02x | 0.00x | CA$-1.15 Million |
| 2017 | 0.00% | -146.76% | 1.63x | 0.00x | CA$-1.45 Million |
| 2018 | 0.00% | -385.00% | 1.67x | 0.00x | CA$-4.03 Million |
| 2019 | 0.00% | -380.86% | 1.97x | 0.00x | CA$-2.99 Million |
| 2020 | 0.00% | -603.60% | 0.72x | 0.00x | CA$-2.99 Million |
| 2021 | 0.00% | -945.40% | 0.77x | 0.00x | CA$-4.96 Million |
| 2022 | 0.00% | -1005.41% | 0.71x | 0.00x | CA$-4.43 Million |
| 2023 | 0.00% | -1004.31% | 0.66x | 0.00x | CA$-3.87 Million |
| 2024 | 0.00% | -745.96% | 0.55x | 0.00x | CA$-2.80 Million |
Industry Comparison
This section compares MedX Health Corp's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $-699,268
- Average return on equity (ROE) among peers: -13.03%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MedX Health Corp (MDX) | CA$-10.02 Million | 0.00% | N/A | $14.23 Million |
| Aurora Spine Corp (ASG) | $5.30 Million | -31.72% | 1.26x | $14.96 Million |
| Cheelcare Inc. (CHER) | $-2.36 Million | 0.00% | 0.00x | $19.63 Million |
| Evome Medical Technologies Inc. (EVMT) | $9.50 Million | -20.26% | 0.02x | $216.32K |
| Frequency Exchange Corp. (FREQ) | $-444.28K | 0.00% | 0.00x | $12.78 Million |
| Imaging Dynamics Company Ltd (IDL) | $-2.77 Million | 0.00% | 0.00x | $374.15K |
| NuGen Medical Devices Inc (NGMD) | $-692.25K | 0.00% | 0.00x | $3.28 Million |
| Perimeter Medical Imaging AI Inc (PINK) | $-16.47 Million | 0.00% | 0.00x | $39.84 Million |
| Therma Bright Inc (THRM) | $-117.47K | 0.00% | 0.00x | $2.31 Million |
| Theralase Technologies Inc. (TLT) | $1.76 Million | -65.32% | 0.52x | $59.41 Million |
About MedX Health Corp
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED … Read more